Dr. John Allan Ellerton, CM, MD
- Medicare services, 2024
- 328
- Medicare patients, 2024
- 68
- Part D claims, 2024
- 559
- Publications
- 3
- Clinical trials
- 10
- Practice address
- 6190 S Ft Apache Rd, Las Vegas, NV 89148
- Practice phone
- Call (702) 877-0814
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Urology Specialists of Nevada
Las Vegas, Nevada
Find Dr. Ellerton's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. John Allan Ellerton is a hematologist and oncologist in Las Vegas, Nevada
Dr. Ellerton practices at Urology Specialists of Nevada in Las Vegas, Nevada.
Dr. Ellerton's NPI, 1962585745, was assigned on October 23, 2006. Dr. Ellerton holds Nevada license 3861.
- NPI
- 1962585745NPI Registry (opens in a new tab)
- NPI enumeration date
- October 23, 2006
- NPI status
- Active
- Practice phone
- (702) 877-0814
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 78
- Medical school graduation
- 1974
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data
Dr. John Allan Ellerton practices at Urology Specialists of Nevada in Las Vegas, Nevada
Dr. Ellerton's primary practice is Urology Specialists of Nevada, at 6190 S Ft Apache Rd, Las Vegas, NV 89148 in Clark County. The practice phone is (702) 877-0814.
- Urology Specialists of Nevada6190 S Ft Apache Rd, Las Vegas, NV 89148 · Clark CountyPhone(702) 877-0814
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. John Allan Ellerton is affiliated with 2 sites of care and 1 medical group
Dr. Ellerton's primary practice is Urology Specialists of Nevada in Las Vegas, Nevada. The medical group on file is Urology Specialists of Nevada. Dmand AI also links Dr. Ellerton to 1 more group practice or clinic, named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. John Allan Ellerton's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ellerton practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Urology Specialists of Nevada | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. John Allan Ellerton is one of 67 hematologists and oncologists in Nevada
Hematology and oncology is Dr. Ellerton's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Ellerton's licenses on file in 2 states: Nevada and California.
Specialties and state licenses
- Hematology and oncology, NevadaPrimary
- California license
Hematologists and oncologists near Dr. Ellerton
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. John Allan Ellerton billed Medicare for 328 services in 2024
CMS data shows 328 Medicare services from Dr. Ellerton across 5 procedure codes in 2024, for 68 Medicare patients. Medicare paid $8,672 for them. Every service was in an office.
Dr. Ellerton's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 02024: 172
- Office and hospital visits
- 2023: 1182024: 8032%
- Tests and treatments
- 2023: 662024: 5221%
- Lab and pathology
- 2023: 472024: 2449%
Dr. Ellerton compared with the Nevada median for hematologists and oncologists, 2024
- Dr. Ellerton
- Nevada median
- Medicare services
- 328vs 19,90098% below
- Medicare patients
- 68vs 60389% below
- Part D claims
- 388vs 79351% below
Medians across 67 hematologists and oncologists in Nevada with Dmand AI profiles that report each measure.
Dr. Ellerton's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Ellerton?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Ellerton and other hematologists and oncologists in Nevada.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. John Allan Ellerton treated 68 Medicare patients in 2024, average age 71
CMS counts 68 Medicare patients who saw Dr. Ellerton in 2024. The largest group is 65 to 74, with 36 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Ellerton's median patient age at 73, with 55% women.
Dr. Ellerton's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Ellerton's Medicare patients by sex, 2024
- Women3856%
- Men3044%
Chronic conditions among Dr. Ellerton's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis38%
- Cancer38%
- Diabetes35%
- Chronic kidney disease29%
- Mood disorders24%
- Atrial fibrillation22%
Share of Medicare patients with each condition. A patient can have several.
Dr. Ellerton's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 73
Patient panel by sex, all payers
- Women55%
- Men44%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. John Allan Ellerton wrote 559 Medicare Part D claims in 2024
In 2024, Dr. Ellerton wrote 559 Medicare Part D claims for 111 patients. 70% of them were for generic drugs. CMS names the drug for 388 of them, across 17 drugs with 11 or more claims each, at $1,390,581 in total drug cost. In 2023, CMS named 560 claims across 23 drugs.
Dr. Ellerton's Part D claims by kind of drug, 2024
- Generic392 claims70%
- Brand-name167 claims30%
Dr. Ellerton's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 5602024: 38831%
Drugs named by CMS: 17 in 2024, 23 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. John Allan Ellerton scored 90 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Ellerton for performance year 2024, reported as part of a group.
Dr. Ellerton's MIPS scores, performance year 2024
- 90of 100Final score
- 82.6of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 83of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. John Allan Ellerton has 3 publications on record
Dmand AI links 3 papers to Dr. Ellerton in 2017. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols. Dr. Ellerton's most frequent co-authors are Manish Agrawal, MD, Jeffrey R. Infante, MD and Nabil Adra, MD.
Topics Dr. Ellerton writes about most
- Antineoplastic Combined Chemotherapy Protocols
Dr. Ellerton's most frequent co-authors
Recent publications by Dr. Ellerton
Clin Cancer Res
See who Dr. Ellerton researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Ellerton works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. John Allan Ellerton has worked on 10 clinical trials
Dmand AI links Dr. Ellerton to 10 clinical trials, 5 of them phase 3 studies. 7 are still active or recruiting. Conditions studied include Oropharyngeal Neoplasms, Pharyngeal Neoplasms and Adenocarcinoma Of Esophagus. National Cancer Institute (NCI) sponsors the most, 8.
Clinical trials with Dr. Ellerton by phase
- NonePhase 1: no trials
- 2Phase 2: 2 trials
- 2Phase 2/3: 2 trials
- 5Phase 3: 5 trials
- NonePhase 4: no trials
Trials with no phase (devices, behavioral studies) are left out.
Conditions in Dr. Ellerton's trials
- Oropharyngeal Neoplasms
- Pharyngeal Neoplasms
- Adenocarcinoma Of Esophagus
- Adenocarcinoma of Lung
- Burkitt Lymphoma
Investigators on the most trials with Dr. Ellerton
- Bryan A. Faller, MD8 shared trials
- Alison K. Conlin, MD7 shared trials
- Gregory A. Masters, MD7 shared trials
Recent clinical trials with Dr. Ellerton
EROS: Engendering Reproductive Health Within Oncologic Survivorship (opens in a new tab)
Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. John Allan Ellerton received $15,573 in industry payments from 2016 to 2025
CMS Open Payments shows 984 general payments to Dr. Ellerton from 67 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Amgen Inc. paid the most, $2,157.
General payments to Dr. Ellerton by program year, 2016 to 2025
General payments to Dr. Ellerton by kind, 2016 to 2025
- Food and beverage$14,58694%
- Education$9876%
Companies that paid Dr. Ellerton the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. John Allan Ellerton's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. John Allan Ellerton
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. John Allan Ellerton's NPI number?
Dr. John Allan Ellerton's NPI number is 1962585745. It was assigned on October 23, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. John Allan Ellerton?
Dr. John Allan Ellerton is a hematologist and oncologist in Las Vegas, Nevada. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. John Allan Ellerton practice?
Dr. Ellerton practices at 6190 S Ft Apache Rd, Las Vegas, NV 89148. Dr. Ellerton's primary practice is Urology Specialists of Nevada in Las Vegas, Nevada. Dmand AI also links Dr. Ellerton to 1 group practice or clinic.
What is Dr. John Allan Ellerton's office phone number?
The practice phone on file for Dr. Ellerton is (702) 877-0814.
What is Dr. John Allan Ellerton's medical license number?
Dr. Ellerton holds Nevada license 3861, one of the licenses on file in 2 states.
Which states has Dr. John Allan Ellerton been licensed in?
Dmand AI has state licenses on file for Dr. Ellerton in Nevada and California.
What medical group is Dr. John Allan Ellerton part of?
Dr. Ellerton is linked to Urology Specialists of Nevada.
Does Dr. John Allan Ellerton accept Medicare?
Yes. CMS data shows Dr. Ellerton billed Medicare for 328 services in 2024.
What is Dr. John Allan Ellerton's MIPS score?
Dr. Ellerton's MIPS final score for performance year 2024 is 90 out of 100, reported as part of a group.
How many Medicare patients does Dr. John Allan Ellerton see?
CMS counts 68 Medicare patients who saw Dr. Ellerton in 2024, with an average age of 71.
Show 6 more questionsShow fewer questions
What services does Dr. John Allan Ellerton bill to Medicare?
In 2024, Dr. Ellerton's most billed Medicare services were injected or infused drug (J1100), office visit, established patient (99214) and infusion or chemotherapy administration (96367).
What drugs does Dr. John Allan Ellerton prescribe most?
In 2024 Medicare Part D data, Dr. Ellerton's most prescribed drugs by claims were Letrozole, Prednisone and Gabapentin.
Has Dr. John Allan Ellerton received payments from drug or device companies?
CMS Open Payments shows $15,573 in general payments to Dr. Ellerton from 67 companies from 2016 to 2025. The largest total came from Amgen Inc.
How long has Dr. John Allan Ellerton been practicing?
Dr. Ellerton graduated from medical school in 1974, 52 years ago.
Does Dr. John Allan Ellerton do research?
Dmand AI links 3 publications to Dr. Ellerton. Dr. Ellerton has worked on 10 clinical trials.
Who does Dr. John Allan Ellerton publish with?
Dr. Ellerton's most frequent co-authors are Manish Agrawal, MD (2 shared papers), Jeffrey R. Infante, MD (2 shared papers) and Nabil Adra, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in Nevada by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card